FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

WIELISA ANTI-GBM TEST SYSTEM

K Number: K974169 · Decision Feb 17, 1998
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
23
Applicant Total
5
Review Days
104

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
WIELISA ANTI-GBM TEST SYSTEM
K Number
K974169
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.5660
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Wieslab AB
Date Received
November 5, 1997
Decision Date
February 17, 1998
Product Code
DBL
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DBL), ordered by most recent decision date.

View all

Other Clearances by Wieslab AB

K Number Device Name
K981748 WIELISA ANCA SCREENING KIT TEST SYSTEM
K981750 WIELISA ANTI-GBM, ANCA SCREENING KIT TEST SYSTEM
K974166 WIELISA MPO ANCA TEST SYSTEM
K974167 WIELISA PR-3 ANCA TEST SYSTEM